Authors: Sabbe, R Picchio, GR Pastore, C Chaloin, O Hartley, O Offord, R Mosier, DE

Citation: R. Sabbe et al., Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression, J VIROLOGY, 75(2), 2001, pp. 661-671

Authors: Picchio, GR Valdez, H Sabbe, R Landay, AL Kuritzkes, DR Lederman, MM Mosier, DE

Citation: Gr. Picchio et al., Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy, J ACQ IMM D, 25(4), 2000, pp. 289-295

Authors: Poignard, P Sabbe, R Picchio, GR Wang, M Gulizia, RJ Katinger, H Parren, PWHI Mosier, DE Burtons, DR

Citation: P. Poignard et al., Neutralizing antibodies have limited effects on the control of establishedHIV-1 infection in vivo, IMMUNITY, 10(4), 1999, pp. 431-438

Authors: Mosier, DE Picchio, GR Gulizia, RJ Sabbe, R Poignard, P Picard, L Offord, RE Thompson, DA Wilken, J

Citation: De. Mosier et al., Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants, J VIROLOGY, 73(5), 1999, pp. 3544-3550

Authors: Spapen, H Damas, P D'Orio, V Sabbe, R Vogelaers, D Byl, B Knockaert, D

Citation: H. Spapen et al., Consensus statement on the treatment of septic shock, ACT CLIN B, 54(5), 1999, pp. 256-262